automated biobanking - the next big leap for biorepositories
DESCRIPTION
An analyst briefing about automated biobanking and what is next for biorepositories.TRANSCRIPT
Automated Automated BiobankingBiobanking--The The Next Big Leap for Next Big Leap for BiorepositoriesBiorepositories
Divyaa Ravishankar, Senior Research Analyst
HealthcareHealthcare
24 April 2012
© 2012 Frost & Sullivan. All rights reserved. This document contains highly confidential information and is the sole property of Frost & Sullivan. No part of it may be circulated, quoted, copied or otherwise reproduced without the written approval of Frost & Sullivan.
Today’s Presenter
Functional Expertise
� 7 years of life sciences expertise which mainly constitutes lab research and market research.
� Working with new technologies incorporated in lab research.
� Identifying emerging technologies and tracking technological and market developments across the life sciences domain.
� Competitive Intelligence, Qualitative Research (Primary and Secondary Research),Competitive Analysis, Company Best Practices Analysis, Spreadsheet Market Sizing and Forecasting Models, Research Design, Client Relationship Management.
Industry Expertise
Place photo hereShadow Background for effect
2
� Industry Expertise
� Lab research experience in the areas such as:
- Diagnostic Testing by Immuno-Chromatographic Techniques.
- Genetic Testing & HLA typing.
� Experience base covering broad range of sectors, leveraging long-standing working relationships with leading industry participants globally in areas like:
- Drug Discovery
- Clinical Diagnostics
- Pharmaceuticals and Biotechnology
- Donor Registries
Education
• Master of Science (Hons.) in Biological Sciences from Birla Institute of Technology and Science, Pilani, India.
Divyaa Ravishankar
Senior Research Analyst,
Healthcare - EuropeFrost & Sullivan
Focus Points
Automated Biobanking – The Next Big Leap for Biorepositories
Automated Biobanking Global Overview – Key Segments of Growth
Industry Drivers & Challenges
Biobanking Needs – Demand Analysis
1.
2.
3.
3
Focus Points
Biobanking Needs – Demand Analysis
Segment wise – Key Market Participants
Regional Focus and Key projects
Key Strategies and Conclusions
3.
4.
5.
6.
Market Overview
Goal• Analyze the dynamics and trends of automation into the biobanking sector and project the future outlook for
the various segments globally for the base year 2011 and the forecast period 2012-2018.
Market Definition.
• Biobanks range from informal storage of hundreds of specimen in an individual freezer to large scale formal repositories that manage millions of specimens.
Market Segments
4
. • Liquid handling and robotics, Automated compound storage and other sample management systems, LIMS and
Consumables
Market Summary
• The global automation market for biobanking application in 2011 accounted for $818.0 Million growing at a CAGR of 8.2 percent.
• Each year around 100 million samples are being added to the biobanks worldwide.
Segment Overview
Revenue by Segment
Source: Frost & Sullivan analysis.
5
Automated Liquid Handling
Systems & Robotics
Automated Compound
Storage & Sample Management
systems
Laboratory Information
Management Systems (LIMS)
Consumables
• Robotic arms and
automated sample
processors
• Nucleic acid preparation
systems
• Fractionation systems
• Low volume and high
volume sample dispensing
workstations
• Bench top pipetting
platforms
• Multiprobe dispensing
heads
• Solutions that help in:
• Automated Sample retrieval ,
storage and management.
• Automated management of
sample libraries
• Large and small-scale storage
of compounds held in varying
plate and tube formats
• Ambient to -80 degree cold
stores
Data management of biosample
storage- aided by various
sample management softwares
Vials,Seals
Barcode labels,
Tips,
Deep well Microplate
Microfuge
Tubes/Storage Tubes
Source: Frost & Sullivan analysis.
Workflow and Equipment Portfolio
Sample Collection
Transportation
Sample
Sample Processing and Liquid Handling
Biobanking Workflow Equipment Portfolio
6
Sample
Processing
Sample Storage
Analysis,
Reporting and
Billing
LIMS Automated Cold Storage
Consumables
Analytical Tools
LIMS
Source: Frost & Sullivan analysis.
Challenges and Drivers
Challenges����Technological challenges arising due to comparison of research results obtained by using specimens from two different biobanks as no two biobanks operate in a similar way.���� Funding and financial maintenance of public biobanks infrastructure becoming tougher in the long run.���� Automation in the area of sample storage and retrieval systems still immature for ultra low temperatures and longer durations.
7
Opportunities
���� Increased growth perceived in Europe and Asia owing to upcoming population and disease based biobank projects.���� Automation increases the efficiency of a biobank.���� Increased LIMS capabilities enhance the prospects and degree of automation within the biobank community.
Source: Frost & Sullivan.
Organizational ChallengesDash Board
Score
Obtaining Funding for Systems
Support from Upper
Management
Demand Analysis
Key Findings of Frost & Sullivan End User Survey
0
5
10LowLow HighHigh
0
5
10
Biobank Access
Completely Free
25.0%
Free & Restricted
50.0%
8
Management
Qualified Staff to Operate
Time and Resource for Training
on System
Justify ROI/ System
Accountability
0 10LowLow HighHigh
0
5
10LowLow HighHigh
0
5
10LowLow HighHigh
0
5
10LowLow HighHigh
Both Free & Paid5.0%
Only Paid Services
20.0%
Interest in Automation
10 being high level challenge;5 being medium level challenge0 being low level challenge
Source: Frost & Sullivan analysis.
Source: Frost & Sullivan analysis.
Key Market Participants
TecanTecan
Automated Liquid Handling & robotics
Automated Compound Storage & Sample
Management systems
Brooks Life ScienceBrooks Life Science
Key Segment Participants
Beckman CoulterBeckman Coulter EppendorfEppendorf HamiltonHamilton Perkin ElmerPerkin Elmer Thermo Fisher ScientificThermo Fisher Scientific
TAP BiosystemsTAP Biosystems Brooks Life ScienceBrooks Life Science Hudson RoboticsHudson Robotics CybioCybio AutogenAutogenAgilentTechnologiesAgilentTechnologies
Matrical BiosciencesMatrical Biosciences
TTP LabtechTTP Labtech
Liconic InstrumentsLiconic Instruments
TAP BiosystemsTAP Biosystems
Thermo Fisher ScientificThermo Fisher Scientific
9
Management systems
LIMS
Consumables
Matrical BiosciencesMatrical Biosciences Liconic InstrumentsLiconic Instruments Thermo Fisher ScientificThermo Fisher Scientific
Thermo Fisher ScientificThermo Fisher Scientific
LabvantageLabvantage
Starlims CorpStarlims Corp
LabwareLabware Perkin ElmerPerkin Elmer
OcimumBiosolutionsOcimumBiosolutions
AutoscribeAutoscribe
MicronicMicronicCorning LifeScienceCorning LifeScience
Thermo FisherScientificThermo FisherScientific
HamiltonHamilton
WheatonWheaton
MatricalBioscienceMatricalBioscience
EppendorfEppendorf
Brooks Life ScienceBrooks Life Science
TAP BiosystemsTAP Biosystems
Greiner Bio - OneGreiner Bio - One
TecanTecan
Source: Frost & Sullivan analysis.
Regional Analysis
Regional Revenue Contribution Growth Rate Trends
10
NORTH AMERICA EUROPE ASIA Rest of World
The United States Western Europe India Africa
Canada Eastern Europe East Asia (China. Korea, Taiwan) South America
South East Asia ( Malaysia, Singapore, Indonesia )Oceania (Australia and
New Zealand)
Middle East Asia
Source: Frost & Sullivan analysis. Source: Frost & Sullivan analysis.
Strategic Conclusions & Recommendations
The falling cost of genomic technologies is expanding the scale and
scope of biobanking research.
Pharma companies are
Strategic alliances and partnerships with technology leaders, academic biobanks and small regional participants will enhance market penetration.
Strategic alliances and partnerships with technology leaders, academic biobanks and small regional participants will enhance market penetration.
So What?
Understanding the needs of the biobank and addressing the infrastructure limitations is the Understanding the needs of the biobank and addressing the infrastructure limitations is the
11
Pharma companies are moving towards
outsourcing to third party biobanks.
Vertical integration is one of the ongoing methods to tide over the different technologies existent for laboratory automation in a cost-
effective manner
Adapting open standards in development alleviates compatibility issuesAdapting open standards in development alleviates compatibility issues
addressing the infrastructure limitations is the key to the success of automation systems.addressing the infrastructure limitations is the key to the success of automation systems.
Source: Frost & Sullivan analysis.
Legal Disclaimer
Frost & Sullivan takes no responsibility for the incorrect information supplied to us by manufacturers or users. Quantitative market information is based primarily on interviews and therefore is subject to fluctuation. Frost & Sullivan research services are limited publications containing valuable market information provided to a select group of customers. Our customers acknowledge, when ordering or downloading, that Frost & Sullivan Research Services are for customers’ internal use and not for general publication or disclosure to third parties. No part of this Research Service may be given, lent, resold or disclosed to noncustomers without written permission. Furthermore, no part may be reproduced, stored in a retrieval system, or transmitted in any form or by any means,
12
reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the permission of the publisher.
• For information regarding permission, write to:
Frost & Sullivan
331 E. Evelyn Ave. Suite 100
Mountain View, CA 94041
Next Steps
Develop Your Visionary and Innovative SkillsGrowth Partnership Service Share your growth thought leadership and ideas or
join our GIL Global Community
13
Join our GIL Community NewsletterKeep abreast of innovative growth opportunities
Your Feedback is Important to Us
Growth Forecasts?
Competitive Structure?
What would you like to see from Frost & Sullivan?
14
Emerging Trends?
Strategic Recommendations?
Other?
Please inform us by “Rating” this presentation.
Follow Frost & Sullivan on Facebook, LinkedIn, SlideShare, and Twitter
http://www.facebook.com/FrostandSullivan
http://www.linkedin.com/companies/4506
15
http://twitter.com/frost_sullivan
http://www.linkedin.com/companies/4506
http://www.slideshare.net/FrostandSullivan
For Additional InformationFor Additional Information
Janique Morvan
Corporate Communications
Healthcare
+ 33 (0) 679 22 4142
Noel Anderson
European Vice President
New Business Development
+44 (0) 207 343 8389
Ranjith Gopinathan
Program Manager
Healthcare
0091 (0) 44 66814242
Siddharth Saha
Director of Research
Healthcare
0044 (0) 207 343 8374